Abstract: In a phase I clinical trial, patients with oral precancers who received immunotherapy injected directly into their lesions experienced tumor shrinkage and no dose-limiting toxicities. The findings suggest that immunotherapy could play a role in cancer prevention.
A Tue, study studied this question.